Splenectomy in children with mild hereditary spherocytosis

Sani M. Roy, George R. Buchanan, Shelley E. Crary

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Splenectomy is considered the treatment of choice for patients with "symptomatic" hereditary spherocytosis (HS). Published guidelines offering recommendations for splenectomy in HS categorize patients primarily based on hemoglobin concentration. We performed a retrospective review of 64 children having splenectomy for HS at Children's Medical Center Dallas. On the basis of hemoglobin concentration alone, 16 children (25%) had mild, 38 (59%) moderate, and 10 (16%) severe HS. However, when reticulocyte count was used to categorize disease severity, only 3 patients (5%) having splenectomy would be considered mild, 17 (27%) moderate, and 42 (66%) severe. Despite otherwise having "mild" disease defined by near-normal hemoglobin levels, many children with nontraditional or subjective signs and symptoms related to hemolytic rate received a splenectomy, and, therefore, reticulocyte count might be a more reliable laboratory marker suggesting consideration of splenectomy. A validated assessment tool incorporating quality of life indicators in addition to the traditional medical indications for splenectomy in HS would be valuable in assessing indications for the procedure.

Original languageEnglish (US)
Pages (from-to)430-433
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume35
Issue number6
DOIs
StatePublished - Aug 2013

Fingerprint

Hereditary Spherocytosis
Splenectomy
Reticulocyte Count
Hemoglobins
Signs and Symptoms
Biomarkers
Quality of Life
Guidelines

Keywords

  • hereditary spherocytosis
  • quality of life
  • severity
  • splenectomy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Splenectomy in children with mild hereditary spherocytosis. / Roy, Sani M.; Buchanan, George R.; Crary, Shelley E.

In: Journal of Pediatric Hematology/Oncology, Vol. 35, No. 6, 08.2013, p. 430-433.

Research output: Contribution to journalArticle

@article{f52323c706ec43b4af381ecd730c2cd7,
title = "Splenectomy in children with mild hereditary spherocytosis",
abstract = "Splenectomy is considered the treatment of choice for patients with {"}symptomatic{"} hereditary spherocytosis (HS). Published guidelines offering recommendations for splenectomy in HS categorize patients primarily based on hemoglobin concentration. We performed a retrospective review of 64 children having splenectomy for HS at Children's Medical Center Dallas. On the basis of hemoglobin concentration alone, 16 children (25{\%}) had mild, 38 (59{\%}) moderate, and 10 (16{\%}) severe HS. However, when reticulocyte count was used to categorize disease severity, only 3 patients (5{\%}) having splenectomy would be considered mild, 17 (27{\%}) moderate, and 42 (66{\%}) severe. Despite otherwise having {"}mild{"} disease defined by near-normal hemoglobin levels, many children with nontraditional or subjective signs and symptoms related to hemolytic rate received a splenectomy, and, therefore, reticulocyte count might be a more reliable laboratory marker suggesting consideration of splenectomy. A validated assessment tool incorporating quality of life indicators in addition to the traditional medical indications for splenectomy in HS would be valuable in assessing indications for the procedure.",
keywords = "hereditary spherocytosis, quality of life, severity, splenectomy",
author = "Roy, {Sani M.} and Buchanan, {George R.} and Crary, {Shelley E.}",
year = "2013",
month = "8",
doi = "10.1097/MPH.0b013e31829f3460",
language = "English (US)",
volume = "35",
pages = "430--433",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Splenectomy in children with mild hereditary spherocytosis

AU - Roy, Sani M.

AU - Buchanan, George R.

AU - Crary, Shelley E.

PY - 2013/8

Y1 - 2013/8

N2 - Splenectomy is considered the treatment of choice for patients with "symptomatic" hereditary spherocytosis (HS). Published guidelines offering recommendations for splenectomy in HS categorize patients primarily based on hemoglobin concentration. We performed a retrospective review of 64 children having splenectomy for HS at Children's Medical Center Dallas. On the basis of hemoglobin concentration alone, 16 children (25%) had mild, 38 (59%) moderate, and 10 (16%) severe HS. However, when reticulocyte count was used to categorize disease severity, only 3 patients (5%) having splenectomy would be considered mild, 17 (27%) moderate, and 42 (66%) severe. Despite otherwise having "mild" disease defined by near-normal hemoglobin levels, many children with nontraditional or subjective signs and symptoms related to hemolytic rate received a splenectomy, and, therefore, reticulocyte count might be a more reliable laboratory marker suggesting consideration of splenectomy. A validated assessment tool incorporating quality of life indicators in addition to the traditional medical indications for splenectomy in HS would be valuable in assessing indications for the procedure.

AB - Splenectomy is considered the treatment of choice for patients with "symptomatic" hereditary spherocytosis (HS). Published guidelines offering recommendations for splenectomy in HS categorize patients primarily based on hemoglobin concentration. We performed a retrospective review of 64 children having splenectomy for HS at Children's Medical Center Dallas. On the basis of hemoglobin concentration alone, 16 children (25%) had mild, 38 (59%) moderate, and 10 (16%) severe HS. However, when reticulocyte count was used to categorize disease severity, only 3 patients (5%) having splenectomy would be considered mild, 17 (27%) moderate, and 42 (66%) severe. Despite otherwise having "mild" disease defined by near-normal hemoglobin levels, many children with nontraditional or subjective signs and symptoms related to hemolytic rate received a splenectomy, and, therefore, reticulocyte count might be a more reliable laboratory marker suggesting consideration of splenectomy. A validated assessment tool incorporating quality of life indicators in addition to the traditional medical indications for splenectomy in HS would be valuable in assessing indications for the procedure.

KW - hereditary spherocytosis

KW - quality of life

KW - severity

KW - splenectomy

UR - http://www.scopus.com/inward/record.url?scp=84881475103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881475103&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e31829f3460

DO - 10.1097/MPH.0b013e31829f3460

M3 - Article

C2 - 23823113

AN - SCOPUS:84881475103

VL - 35

SP - 430

EP - 433

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 6

ER -